Konsume
Interval Day Week Month
Newswire Search Past 90 Days 10 stories 8 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
alzheimer8-
eisai4-
Prominent Journalists
Byline Articles Written Avg Reach
RTTNews Staff Writer 3 -
Universitat Autònoma de Barcelona (UAB)Jun 5 2026 1 -
Elaine Chen 1 -
Marisa Wexler, MS 1 -
Mari Yamaguchi 1 -
Peter Morales-Brown 1 -
Print this Article 1 -
IBT Staff Reporter 1 -


Alzheimer's: Real-world study confirms Leqembi therapy benefits

Peter Morales-Brownmedicalnewstoday.com


Eisai, Biogen Report Study Showing Long-Term Benefits Of LEQEMBI In Early Alzheimer's Disease

RTTNews Staff Writerrttnews.com


Akero team, backed by Fairmount, launches new immunology company

Elaine Chenstatnews.com


Biogen, Eisai Present Comparable Efficacy, Safety For SC LEQEMBI In Early Alzheimer's Disease

RTTNews Staff Writerrttnews.com


After US approval, Japan approves Leqembi, its first Alzheimer's drug

Mari Yamaguchinbcsandiego.com


Antibody fragment offers safer alternative for Alzheimer disease treatment

Universitat Autònoma de Barcelona (UAB)Jun 5 2026news-medical.net


Eisai Expects Revenue Of JPY 1 Trillion For 2028

RTTNews Staff Writerrttnews.com


FDA Extends Review of Eisai, Biogen Alzheimer's Drug

IBT Staff Reporteribtimes.com


FDA mulls expanded home injections for Alzheimer's drug Leqembi

Marisa Wexler, MSalzheimersnewstoday.com


Biogen beats estimates as Alzheimer’s drug gains momentum - The Boston Globe

Print this Articlebostonglobe.com

Execution: 0.09 Seconds. 47.5 mb used.